Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1011
https://www.valueinhealthjournal.com/article/S1098-3015(15)03087-9/fulltext
Title :
Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03087-9&doi=10.1016/j.jval.2015.09.1011
First page :
A416
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
449